Have to see value where it is miss priced. And what fundamentals are layering together. Collaboration with Siemens, and multiple different cancer targets on the horizon.
Market that to US investors. The Australian market, priced it speculatively at a previous high of 200m mc. Why ? Because the prize of $$ volumes of NPs in a med tech growth space.
Do you want that barbaric biopsy that could actually spread the cancer ? or do you want non invasive ? non radioactive ?
IBX Price at posting:
1.1¢ Sentiment: Buy Disclosure: Held
